Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/20.500.12008/55483
MetadatoEtiquetaValorIdioma
dc.contributor.author Autor Bove, Virginia-
dc.contributor.author Autor Garrido, David-
dc.contributor.author Autor Riva, Eloísa-
dc.contributor.filiacion Filiación Bove Virginia, Hospital Central de las Fuerzas Armadas (Uruguay)-
dc.contributor.filiacion Filiación Garrido David, Universidad de la República (Uruguay). Facultad de Medicina. Hospital de Clínicas-
dc.contributor.filiacion Filiación Riva Eloísa, Universidad de la República (Uruguay). Facultad de Medicina. Hospital de Clínicas; Hospital Central de las Fuerzas Armadas (Uruguay)-
dc.date.accessioned Fecha ingreso 2026-06-12T14:14:21Z-
dc.date.available Fecha disponible 2026-06-12T14:14:21Z-
dc.date.issued Año de publicación 2021-
dc.description.abstract Resumen Background: Multiple myeloma is a disease of the elderly. However, 40% of patients are diagnosed before 65 years old. Outcomes regarding age as a prognostic factor in MM are heterogeneous. Method: We retrospectively analyzed clinical characteristics, response to treatment and survival of 282 patients with active newly-diagnosed multiple myeloma, comparing results between patients younger and older than 65 years. Main results: The frequency of multiple myeloma in those younger than 66 years was 53.2%. Younger patients presented with a more aggressive disease, more advanced Durie-Salmon stage (85.3% vs 73.5%; p=0.013), extramedullary disease (12.7% vs 0%; p<0.001), osteolytic lesions (78.7% vs 57.6%; p<0.001) and bone plasmacytoma (25.3% vs 11.4%; p=0.003). In spite of this, the overall response rate was similar between groups (80.6% vs 81.4%; p=0.866). The overall survival was significantly longer in young patients (median, 65 months vs 41 months; p=0.001) and higher in those who received autologous hematopoietic stem cell transplantation. The main cause of death was disease progression in both groups. Multivariable analysis revealed that creatinine ≥2mg/dl, extramedullary disease, ≤very good partial remission and non-autologous hematopoietic stem cell transplantation are independent risk factors for shorter survival. Conclusion: Although multiple myeloma patients younger than 66 years of age have an aggressive presentation, this did not translate into an inferior overall survival, particularly in those undergoing autologous hematopoietic stem cell transplantation.es
dc.format.extent Extensión 8 p.es
dc.format.mimetype Formato application/pdfes
dc.identifier.citation Citación Bove V, Garrido D y Riva E. Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma. Hematology Transfusion and Cell Therapy [en línea]. 2021;43(3):295-302es
dc.identifier.doi DOI 10.1016/j.htct.2020.06.014-
dc.identifier.eissn e-ISSN 2531-1387-
dc.identifier.uri URI https://hdl.handle.net/20.500.12008/55483-
dc.language.iso Idioma enes
dc.publisher Editorial Elsevieres
dc.relation.ispartof EN Hematology, Transfusion and Cell Therapy. 2021;43(3):295-302es
dc.rights Derechos Las obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad de la República.(Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014)es
dc.rights.licence Licencia Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacionales
dc.rights.uri Uri de la licencia https://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subject Palabras clave Agees
dc.subject Palabras clave Multiple myelomaes
dc.subject Palabras clave Survivales
dc.subject Palabras clave Transplantationes
dc.subject.other Descriptores TRASPLANTE DE CÉLULASes
dc.subject.other Descriptores ADULTO JOVENes
dc.subject.other Descriptores MIELOMA MÚLTIPLEes
dc.subject.other Descriptores TASA DE SUPERVIVENCIAes
dc.title Título Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myelomaes
dc.type Tipo de documento Artículoes
FicherosDescripciónTamañoFormato
Young age and autologous stem cell transplantation.pdf Young age and autologous stem cell transplantation 2.12 MB Adobe PDF

Licencia Creative Commons:

Excepto donde se indique lo contrario, la licencia de este ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional